(19)
(11) EP 1 372 785 A2

(12)

(88) Date of publication A3:
10.04.2003

(43) Date of publication:
02.01.2004 Bulletin 2004/01

(21) Application number: 02712162.3

(22) Date of filing: 20.02.2002
(51) International Patent Classification (IPC)7A61P 25/06, A61K 31/404
// A61K31:404, A61K31:275
(86) International application number:
PCT/IB2002/000512
(87) International publication number:
WO 2002/070070 (12.09.2002 Gazette 2002/37)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 01.03.2001 GB 0105131

(71) Applicants:
  • Pfizer Limited
    Sandwich,Kent CT13 9NJ (GB)

    GB 
  • PFIZER INC.
    New York, N.Y. 10017 (US)

    AT BE CH CY DE DK ES FI FR GR IE IT LU MC NL PT SE TR LI 

(72) Inventor:
  • HUMPHREY, M.J.,c/o Pfizer Global Research and Dev
    Sandwich,Kent CT13 9NJ (GB)

(74) Representative: Ruddock, Keith Stephen et al
Pfizer Limited,UK Patent Department,Ramsgate Road
Sandwich,Kent CT13 9NJ
Sandwich,Kent CT13 9NJ (GB)

   


(54) COMPOSITIONS HAVING IMPROVED BIOAVAILABILITY OF ELETRIPTAN